Reclassification Guide

More medicines are being reclassified from Prescription-Only Medicines (POMs) to Pharmacy (P) medicines.

Other medicines, such as oral lidocaine-containing products for teething in children, have been reclassified from General Sale List (GSL) medicines to Pharmacy (P) medicines.

We've produced guidance to support you when selling or supplying these medicines.

Join our webinar

How to navigate medicines reclassifications (RPS/MHRA)

Tuesday| 30 March 7pm

In this webinar, we will hear from the Medicines and Healthcare products Regulatory Agency (MHRA) to get behind the scenes insights into how decisions around reclassifications are made. We will also discuss legal, professional, and ethical considerations that you should consider when adapting your practice for a classification change.

Register now

Become a Royal Pharmaceutical Society member to view this content.

Join today Log in

12 months of membership for the price of 11

We all feel like we've missed out in 2020, so we want to give you something back for 2021.

Get your 12 months of RPS membership for the price of 11, when you renew before 28 February, using annual direct debit. That’s an extra month, completely free, saving you up to £19!

Over that 12 months you'll get:

An exciting program of vital webinars (at least one webinar a week!)

Our brand new digital MEP, coming in 2021

All the support you need during COVID-19.

With your support, we can continue advocating for pharmacy in the coming year and supporting our members everywhere.